Fultz; Kimberly Elizabeth

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fultz; Kimberly Elizabeth.The latest application filed is for "methods for treating cancer using tor kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines".

Company Profile

0.4.7

Fultz; Kimberly Elizabeth - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines Grant 10,004,735 - Fultz , et al. June 26, 2	2018-06-26
METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY COMPRISING ADMINISTERING SUBSTITUTED PYRAZINO[2,3-b]PYRAZINES App 20170312278 - FULTZ; Kimberly Elizabeth ; et al.	2017-11-02
Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines Grant 9,737,535 - Fultz , et al. August 22, 2	2017-08-22
Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for tor kinase inhibitory activity Grant 9,557,338 - Xu , et al. January 31, 2	2017-01-31
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20160024101 - ELSNER; Jan ; et al.	2016-01-28
Inhibition Of Phosphorylation Of Pras40, Gsk3-beta Or P70s6k1 As A Marker For Tor Kinase Inhibitory Activity App 20150362505 - Xu; Weiming ; et al.	2015-12-17
Methods For Treating Cancer Using Tor Kinase Inhibitor Combination Therapy App 20150297590 - FULTZ; Kimberly Elizabeth ; et al.	2015-10-22
Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity Grant 9,155,736 - Xu , et al. October 13, 2	2015-10-13
Treatment Of Cancer With Tor Kinase Inhibitors App 20140113904 - Mortensen; Deborah ; et al.	2014-04-24
Inhibition Of Phosphorylation Of Pras40, Gsk3-beta Or P70s6k1 As A Marker For Tor Kinase Inhibitory Activity App 20140113905 - Xu; Weiming ; et al.	2014-04-24
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20130289271 - Perrin-Ninkovic; Sophie ; et al.	2013-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.